Women of Malta. [ Take the quiz → ]

Symptoms & questions

Menopause weight gain and belly fat: it's physiology, not willpower

Falling estrogen shifts where your body stores fat — away from hips and thighs and toward the abdomen — while also reducing muscle mass and insulin sensitivity. So the same diet that always held your weight steady now gains it, and it lands around the middle. This is a physiological change of the menopause transition, not a failure of discipline. Understanding the mechanism is what lets you target it instead of blaming yourself.

Last verified: 10 July 2026 · reviewed against NICE NG23 and menopause metabolic research · re-verified quarterly

Why belly fat specifically?

Before menopause, higher estrogen tends to direct fat storage to the hips and thighs. As estrogen falls, that pattern flips: fat is preferentially stored as visceral fat around the abdomen. That's why women who never carried weight around the middle suddenly do — and why the change can feel like it happened to a different body.

Two other shifts compound it. Estrogen loss accelerates muscle loss (see menopause muscle loss), and muscle is metabolically expensive tissue — losing it lowers the calories you burn at rest. And insulin sensitivity drops, so the body handles carbohydrate less efficiently. Together, these mean the same intake now tips into storage rather than balance.

Does HRT cause or prevent weight gain?

This is one of the most persistent myths, so it's worth stating plainly: the recognised position is that HRT does not cause weight gain. The weight gain of midlife is driven by ageing and the hormonal transition itself — it happens with or without HRT. In fact, some evidence suggests HRT may limit the visceral (abdominal) shift of fat. Whether HRT is right for you is a separate question that depends on your stage and history; see HRT in Malta and discuss it with a doctor.

What actually helps?

Because the real drivers are muscle loss and insulin resistance, "eat less, move more" underperforms here. The levers that genuinely move it:

The GLP-1 question in 2026

You can't discuss midlife weight in 2026 without it: GLP-1 medications (the appetite-regulating injectables) are increasingly being used alongside menopause care. This is a recognised and fast-evolving trend rather than a settled protocol. They are prescription medicines with genuine considerations, benefits and trade-offs — so whether they fit you is a decision for a doctor, not a webpage. We name the trend so you can raise it; we don't hand out doses or regimens. That sequencing — the honest conversation to have with your prescriber — is exactly what belongs in a consultation.

Where to have that conversation in Malta

Menopause weight gain, HRT and GLP-1 medications are all private-pay conversations in Malta as of July 2026 — there's no dedicated public menopause clinic, and HRT isn't on the Government Formulary for menopause. In practice that means a private gynaecologist or GP (standalone consultations are typically quoted around €50–80; the fee is confirmed when you book). Going in able to name what you want to discuss — the hormonal shift, strength and protein, and whether a GLP-1 is appropriate for you — makes that paid appointment count. See finding a menopause doctor in Malta.

First question first: what's your stage?

The metabolic shift starts at a specific point in the transition. The free quiz places you in one of the 7 stages in about 10 minutes.

Take the free quiz →

The Malta Menopause Kit includes the named-clinic directory, the GP conversation script and a sequenced plan for your stage — see the kit.

Sources

  1. NICE NG23: Menopause — identification and management (UK), including HRT and weight — nice.org.uk/guidance/ng23.
  2. International Menopause Society (IMS) resources on menopause, body composition and metabolic change — imsociety.org.
  3. GLP-1 medications in midlife/menopause care — recognised 2026 clinical trend; summarised in project research; checked 10 July 2026.
  4. Government Formulary List (Outpatients), Directorate for Pharmaceutical Affairs, Malta — HRT not publicly funded for menopause — pharmaceuticalaffairs.gov.mt. List dated 16 June 2026.